Clinical Commissioning Policy: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Document first published:
Page updated:
Topic:
Publication type:

Stereotactic ablative radiotherapy (SABR) is recommended to be available as a treatment option through routine commissioning for the treatment of previously irradiated, locally recurrent primary pelvic tumours within the criteria set out in this document.

Document

Clinical Commissioning Policy: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Clinical Commissioning Policy: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 267 KB
  • 11 pages

Document

Evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 909 KB
  • 57 pages

Document

Public health evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Public health evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 59 KB
  • 2 pages

Document

Engagement report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Engagement report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 161 KB
  • 5 pages

Document

Commissioning through Evaluation report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Commissioning through Evaluation report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 3 MB
  • 329 pages

Document

CPAG summary report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

CPAG summary report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 158 KB
  • 8 pages

Document

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 158 KB
  • 14 pages

Document

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages) - February 2020

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages) - February 2020

  • PDF
  • 97 KB
  • 2 pages

Document

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages) - August 2019

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages) - August 2019

  • PDF
  • 71 KB
  • 2 pages

Document

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (All ages)

  • PDF
  • 24 KB
  • 2 pages